Following the reverse share split, the Company will have approximately 5,079,000 Ordinary Shares issued and outstanding REHOVOT, Israel, July 23, 2024 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the “Company” or “Evogene”), a leading computational biology company targeting…